# US 2009/0221808 A1 · Process for the Preparation of Nucleic Acid Duplexes

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0221808 A1
- Document ID: US20090221808A1
- Status: Published application
- Kind: A1
- Application number: 12/092,942
- Filed: 2006-11-03
- Published: 2009-09-03
- Earliest claimed: 2005-11-07
- Inventors: Michael J. Fazio
- Web page: https://patentgrep.com/patent/US20090221808A1

## CPC

- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C12N 15/10: Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34)
- C12N 2310/14: interfering nucleic acids [NA]
- C12N 2330/30: chemically synthesised
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

The invention is a process for the preparation of at least one nucleic acid duplex by the steps of: (a) synthesizing a first single strand oligonucleotide to produce a crude solution of the first single strand oligonucleotide; (b) purifying the first single strand oligonucleotide from the crude solution by first liquid chromatography to produce a solution of purified first single strand oligonucleotide in a first liquid chromatography eluant; (c) synthesizing a second single strand oligonucleotide to produce a crude solution of the second single strand oligonucleotide; (d) purifying the second single strand oligonucleotide from the crude solution by second liquid chromatography to produce a solution of purified second single strand oligonucleotide in a second liquid chromatography eluant; (e) mixing the solution of purified first single strand oligonucleotide in the first liquid chromatography eluant with the solution of purified second single strand oligonucleotide in the second liquid chromatography eluant so that the first and second single strand oligonucleotides can complex to form a nucleic acid duplex in the mixture of first and second liquid chromatography eluants.

## Claims

### Claim 1

A process for the preparation of at least one nucleic acid duplex, comprising the steps of: (a) providing a first single strand oligonucleotide in a crude solution; (b) purifying the first single strand oligonucleotide from the crude solution by first liquid chromatography to produce a solution of purified first single strand oligonucleotide in a first liquid chromatography eluant; (c) providing a second single strand oligonucleotide which has a complementary or partially complementary sequence to the first single strand oligonucleotide in a crude solution; (d) purifying the second single strand oligonucleotide from the crude solution by second liquid chromatography to produce a solution of purified second single strand oligonucleotide in a second liquid chromatography eluant; (e) mixing the solution of purified first single strand oligonucleotide in the first liquid chromatography eluant with the solution of purified second single strand oligonucleotide in the second liquid chromatography eluant so that the first and second single strand oligonucleotides can complex to form a nucleic acid duplex in the mixture of first and second liquid chromatography eluants.

### Claim 2 (depends on 1)

The method of claim 1 wherein the step of providing a single strand oligonucleotide comprises synthesizing the single strand oligonucleotide.

### Claim 3 (depends on 1)

The method of claim 1 wherein at least one of the chromatography eluants is stored for more than 24 hours.

### Claim 4 (depends on 1, 3)

The method of claims 1 or 3 wherein the eluant has a pH of greater than and the single strand is DNA.

### Claim 5 (depends on 1, 3)

The method of claim 1 or 3 wherein the eluant comprises an antimicrobial inhibitor.

### Claim 6 (depends on 5)

The method of claim 5 wherein the antimicrobial inhibitor is an organic solvent.

### Claim 7 (depends on 6)

The method of claim 6 wherein the organic solvent is acetonitrile or a lower alcohol.

### Claim 8 (depends on 1)

The process of claim 1, further comprising the step of separating the nucleic acid duplex from the mixture of first and second liquid chromatography eluants by ultrafiltration to produce an aqueous solution of the nucleic acid duplex.

### Claim 9 (depends on 8)

The process of claim 8, further comprising the step of freeze drying the aqueous solution of the nucleic acid duplex to produce a solid comprising the nucleic acid duplex.

### Claim 10 (depends on 1, 4)

The process of claim 1 or 4, further comprising the step of adjusting the pH of the solution of purified first single strand oligonucleotide in a first liquid chromatography eluant before step (e).

### Claim 11 (depends on 1, 4)

The process of claim 1 or 4, further comprising the step of adjusting the pH of the solution of purified second single strand oligonucleotide in a second liquid chromatography eluant before step (e).

### Claim 12 (depends on 1, 4)

The process of claim 1 or 4, further comprising the steps of adjusting the pH of the solution of purified first single strand oligonucleotide in a first liquid chromatography eluant and the step of adjusting the pH of the solution of purified second single strand oligonucleotide in a second liquid chromatography eluant before step (e).

### Claim 13 (depends on 1)

The process of claim 1, farther comprising adjusting the pH of the mixture in step (e).

### Claim 14 (depends on 1)

The process of claim 1, further comprising in step (e) heating and then cooling the mixture of first and second liquid chromatography eluants to anneal the nucleic acid duplex.

### Claim 15 (depends on 1)

The process of claim 1, wherein the nucleic acid duplex is an RNA-RNA duplex.

### Claim 16 (depends on 1)

The process of claim 1, wherein the concentration of the first and second single strand oligonucleotides in step (e) is in the range of from about 0.05 to about 5 wt % of the mixture.

### Claim 17 (depends on 14)

The process of claim 14, wherein the heating and cooling temperature range is from about ninety to about twenty degrees Celsius.

### Claim 18 (depends on 10, 11, 12)

The process of any of claims 10-12, wherein the adjusted pH is in the range of from about five to about ten.

### Claim 19

The process of any of the preceding claims further comprising purifying a third single strand oligonucleotide in crude solution by liquid chromatography to form a third eluant said third single strand has complementary sequence or partially complementary sequence to one of the first two single strands is purified and mixing the third eluant with the first two eluants in the mixing step.

### Claim 20

The process of any of the preceding claims further comprising purifying a third single strand oligonucleotide in crude solution by liquid chromatography to form a third eluant and purifying a fourth single strand oligonucleotide in crude solution by liquid chromatography to form a fourth eluant which fourth single strand oligonucleotide has a complementary sequence or partially complementary sequence to the third single strand oligonucleotide, and in the mixing step mixing the first, second, third and fourth liquid chromatography eluants.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

A nucleic acid duplex made according to the process of any of claims 1-20.
